29 results on '"Novelli, Flavia"'
Search Results
2. BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene × environment interaction with asbestos
- Author
-
Novelli, Flavia, Bononi, Angela, Wang, Qian, Bai, Fang, Patergnani, Simone, Kricek, Franz, Haglund, Ellinor, Suarez, Joelle S., Tanji, Mika, Xu, Ronghui, Takanishi, Yasutaka, Minaai, Michael, Pastorino, Sandra, Morris, Paul, Sakamoto, Greg, Pass, Harvey I., Barbour, Haithem, Gaudino, Giovanni, Giorgi, Carlotta, Pinton, Paolo, Onuchic, Jose N., Yang, Haining, and Carbone, Michele
- Published
- 2021
3. Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma
- Author
-
Bononi, Angela, Goto, Keisuke, Ak, Guntulu, Yoshikawa, Yoshie, Emi, Mitsuru, Pastorino, Sandra, Carparelli, Lorenzo, Ferro, Angelica, Nasu, Masaki, Kim, Jin-Hee, Suarez, Joelle S., Xu, Ronghui, Tanji, Mika, Takinishi, Yasutaka, Minaai, Michael, Novelli, Flavia, Pagano, Ian, Gaudino, Giovanni, Pass, Harvey I., Groden, Joanna, Grzymski, Joseph J., Metintas, Muzaffer, Akarsu, Muhittin, Morrow, Betsy, Hassan, Raffit, Yang, Haining, and Carbone, Michele
- Published
- 2020
4. Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy
- Author
-
Xue, Jiaming, Patergnani, Simone, Giorgi, Carlotta, Suarez, Joelle, Goto, Keisuke, Bononi, Angela, Tanji, Mika, Novelli, Flavia, Pastorino, Sandra, Xu, Ronghui, Caroccia, Natascia, Dogan, A. Umran, Pass, Harvey I., Tognon, Mauro, Pinton, Paolo, Gaudino, Giovanni, Mak, Tak W., Carbone, Michele, and Yang, Haining
- Published
- 2020
5. Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling.
- Author
-
Novelli, Flavia, Yoshikawa, Yoshie, Maria Vitto, Veronica Angela, Modesti, Lorenzo, Minaai, Michael, Pastorino, Sandra, Mitsuru Emi, Jin-Hee Kim, Kricek, Franz, Fang Bai, Onuchic, José N., Bononi, Angela, Suarez, Joelle S., Tanji, Mika, Favaron, Cristina, Zolondick, Alicia A., Ronghui Xu, Yasutaka Takanishi, Zhanwei Wang, and Sakamoto, Greg
- Subjects
- *
P53 protein , *DNA repair , *NATURE & nurture , *MISSENSE mutation , *ECOLOGICAL genetics - Abstract
We report that ~1.8% of all mesothelioma patients and 4.9% of those younger than 55, carry rare germline variants of the BRCA1 associated RING domain 1 (BARD1) gene that were predicted to be damaging by computational analyses. We conducted functional assays, essential for accurate interpretation of missense variants, in primary fibroblasts that we established in tissue culture from a patient carrying the heterozygous BARD1V523A mutation. We found that these cells had genomic instability, reduced DNA repair, and impaired apoptosis. Investigating the underlying signaling pathways, we found that BARD1 forms a trimeric protein complex with p53 and SERCA2 that regulates calcium signaling and apoptosis. We validated these findings in BARD1-silenced primary human mesothelial cells exposed to asbestos. Our study elucidated mechanisms of BARD1 activity and revealed that heterozygous germline BARD1 mutations favor the development of mesothelioma and increase the susceptibility to asbestos carcinogenesis. These mesotheliomas are significantly less aggressive compared to mesotheliomas in asbestos workers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Validation of a biomarker tool capable of measuring the absorbed dose soon after exposure to ionizing radiation
- Author
-
Giovanetti, Anna, Marconi, Raffaella, Awad, Noha, Abuzied, Hala, Agamy, Neveen, Barakat, Mohamed, Bartoleschi, Cecilia, Bossi, Gianluca, Canfora, Marco, Elsaid, Amr A., Ioannilli, Laura, Ismail, Horeya M., Issa, Yasmine Amr, Novelli, Flavia, Pardini, Maria Chiara, Pioli, Claudio, Pinnarò, Paola, Sanguineti, Giuseppe, Tahoun, Mohamed M., Turchi, Riccardo, and Strigari, Lidia
- Published
- 2021
- Full Text
- View/download PDF
7. Peptide-Functionalized and Drug-Loaded Tomato Bushy Stunt Virus Nanoparticles Counteract Tumor Growth in a Mouse Model of Shh-Dependent Medulloblastoma.
- Author
-
Marchetti, Luca, Novelli, Flavia, Tanno, Barbara, Leonardi, Simona, Hizam, Veronica Mohamed, Arcangeli, Caterina, Santi, Luca, Baschieri, Selene, Lico, Chiara, and Mancuso, Mariateresa
- Subjects
- *
TUMOR growth , *MEDULLOBLASTOMA , *PRECANCEROUS conditions , *LABORATORY mice , *NANOMEDICINE , *ANIMAL disease models , *PLANT viruses , *DOXORUBICIN - Abstract
Sonic hedgehog medulloblastoma (SHH-MB) accounts for 25–30% of all MBs, and conventional therapy results in severe long-term side effects. New targeted therapeutic approaches are urgently needed, drawing also on the fields of nanoparticles (NPs). Among these, plant viruses are very promising, and we previously demonstrated that tomato bushy stunt virus (TBSV), functionalized on the surface with CooP peptide, specifically targets MB cells. Here, we tested the hypothesis that TBSV-CooP can specifically deliver a conventional chemotherapeutic drug (i.e., doxorubicin, DOX) to MB in vivo. To this aim, a preclinical study was designed to verify, by histological and molecular methods, if multiple doses of DOX-TBSV-CooP were able to inhibit tumor progression of MB pre-neoplastic lesions, and if a single dose was able to modulate pro-apoptotic/anti-proliferative molecular signaling in full-blown MBs. Our results demonstrate that when DOX is encapsulated in TBSV-CooP, its effects on cell proliferation and cell death are similar to those obtained with a five-fold higher dose of non-encapsulated DOX, both in early and late MB stages. In conclusion, these results confirm that CooP-functionalized TBSV NPs are efficient carriers for the targeted delivery of therapeutics to brain tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Characterization of Early and Late Damage in a Mouse Model of Pelvic Radiation Disease.
- Author
-
Vitali, Roberta, Palone, Francesca, De Stefano, Ilaria, Fiorente, Chiara, Novelli, Flavia, Pasquali, Emanuela, Fratini, Emiliano, Tanori, Mirella, Leonardi, Simona, Tanno, Barbara, Colantoni, Eleonora, Soldi, Sara, Galletti, Serena, Grimaldi, Maria, Morganti, Alessio Giuseppe, Fuccio, Lorenzo, Pazzaglia, Simonetta, Pioli, Claudio, Mancuso, Mariateresa, and Vesci, Loredana
- Subjects
RADIATION injuries ,LABORATORY mice ,ANIMAL disease models ,BIOMARKERS ,ANIMAL models in research ,IRRADIATION ,DOSE-response relationship (Radiation) ,ENDOMETRIOSIS - Abstract
Pelvic radiation disease (PRD), a frequent side effect in patients with abdominal/pelvic cancers treated with radiotherapy, remains an unmet medical need. Currently available preclinical models have limited applications for the investigation of PRD pathogenesis and possible therapeutic strategies. In order to select the most effective irradiation protocol for PRD induction in mice, we evaluated the efficacy of three different locally and fractionated X-ray exposures. Using the selected protocol (10 Gy/day × 4 days), we assessed PRD through tissue (number and length of colon crypts) and molecular (expression of genes involved in oxidative stress, cell damage, inflammation, and stem cell markers) analyses at short (3 h or 3 days after X-ray) and long (38 days after X-rays) post-irradiation times. The results show that a primary damage response in term of apoptosis, inflammation, and surrogate markers of oxidative stress was found, thus determining a consequent impairment of cell crypts differentiation and proliferation as well as a local inflammation and a bacterial translocation to mesenteric lymph nodes after several weeks post-irradiation. Changes were also found in microbiota composition, particularly in the relative abundance of dominant phyla, related families, and in alpha diversity indices, as an indication of dysbiotic conditions induced by irradiation. Fecal markers of intestinal inflammation, measured during the experimental timeline, identified lactoferrin, along with elastase, as useful non-invasive tools to monitor disease progression. Thus, our preclinical model may be useful to develop new therapeutic strategies for PRD treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. BAP1 is a novel regulator of HIF-1α.
- Author
-
Bononi, Angela, Qian Wang, Zolondick, Alicia A., Fang Bai, Steele-Tanji, Mika, Suarez, Joelle S., Pastorino, Sandra, Sipes, Abigail, Signorato, Valentina, Ferro, Angelica, Novelli, Flavia, Jin-Hee Kim, Minaai, Michael, Yasutaka Takinishi, Pellegrini, Laura, Napolitano, Andrea, Ronghui Xu, Farrar, Christine, Goparaju, Chandra, and Bassi, Cristian
- Subjects
TUMOR suppressor genes ,ABDOMEN - Abstract
BAP1 is a powerful tumor suppressor gene characterized by haplo insufficiency. Individuals carrying germline BAP1 mutations often develop mesothelioma, an aggressive malignancy of the serosal layers covering the lungs, pericardium, and abdominal cavity. Intriguingly, mesotheliomas developing in carriers of germline BAP1 mutations are less aggressive, and these patients have significantly improved survival. We investigated the apparent paradox of a tumor suppressor gene that, when mutated, causes less aggressive mesotheliomas. We discovered that mesothelioma biopsies with biallelic BAP1 mutations showed loss of nuclear HIF-1α staining. We demonstrated that during hypoxia, BAP1 binds, deubiquitylates, and stabilizes HIF-1α, the master regulator of the hypoxia response and tumor cell invasion. Moreover, primary cells from individuals carrying germline BAP1 mutations and primary cells in which BAP1 was silenced using siRNA had reduced HIF-1α protein levels in hypoxia. Computational modeling and co-immunoprecipitation experiments revealed that mutations of BAP1 residues I675, F678, I679, and L691 -encompassing the C-terminal domain-nuclear localization signal- to A, abolished the interaction with HIF-1α. We found that BAP1 binds to the N-terminal region of HIF-1α, where HIF-1α binds DNA and dimerizes with HIF-1β forming the heterodimeric transactivating complex HIF. Our data identify BAP1 as a key positive regulator of HIF-1α in hypoxia. We propose that the significant reduction of HIF-1α activity in mesothelioma cells carrying biallelic BAP1 mutations, accompanied by the significant reduction of HIF-1α activity in hypoxic tissues containing germline BAP1 mutations, contributes to the reduced aggressiveness and improved survival of mesotheliomas developing in carriers of germline BAP1 mutations. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Interaction between glutathione-S-transferase polymorphisms, smoking habit, and HPV infection in cervical cancer risk
- Author
-
Palma, Selena, Novelli, Flavia, Padua, Luca, Venuti, Aldo, Prignano, Grazia, Mariani, Luciano, Cozzi, Renata, Tirindelli, Donatella, and Testa, Antonella
- Published
- 2010
- Full Text
- View/download PDF
11. MiRNA-Mediated Fibrosis in the Out-of-Target Heart following Partial-Body Irradiation.
- Author
-
Tanno, Barbara, Novelli, Flavia, Leonardi, Simona, Merla, Caterina, Babini, Gabriele, Giardullo, Paola, Kadhim, Munira, Traynor, Damien, Medipally, Dinesh K. R., Meade, Aidan D., Lyng, Fiona M., Tapio, Soile, Marchetti, Luca, Saran, Anna, Pazzaglia, Simonetta, and Mancuso, Mariateresa
- Subjects
- *
X-rays , *COLLAGEN , *SKELETAL muscle , *CELL culture , *ANIMAL experimentation , *MICRORNA , *FIBROSIS , *RADIATION injuries , *HEART diseases - Abstract
Simple Summary: Radiation exposure has been linked to non-cancer effects such as heart disease. This study aimed to investigate radiation-induced heart disease in mice where the radiation exposure was either administered to the whole body or only to the bottom third of the body (partial body). Radiation damage was found in the hearts of mice following both whole-body and partial-body exposure. MiRNAs released from directly irradiated skeletal muscle cells in vitro were shown to result in damaging effects in unirradiated ventricular cardiac cells. This study suggests that a partial-body exposure to radiation should be thought of as a systemic effect rather than only an effect on the exposed tissue. Recent reports have shown a link between radiation exposure and non-cancer diseases such as radiation-induced heart disease (RIHD). Radiation exposures are often inhomogeneous, and out-of-target effects have been studied in terms of cancer risk, but very few studies have been carried out for non-cancer diseases. Here, the role of miRNAs in the pathogenesis of RIHD was investigated. C57Bl/6J female mice were whole- (WBI) or partial-body-irradiated (PBI) with 2 Gy of X-rays or sham-irradiated (SI). In PBI exposure, the lower third of the mouse body was irradiated, while the upper two-thirds were shielded. From all groups, hearts were collected 15 days or 6 months post-irradiation. The MiRNome analysis at 15 days post-irradiation showed that miRNAs, belonging to the myomiR family, were highly differentially expressed in WBI and PBI mouse hearts compared with SI hearts. Raman spectral data collected 15 days and 6 months post-irradiation showed biochemical differences among SI, WBI and PBI mouse hearts. Fibrosis in WBI and PBI mouse hearts, indicated by the increased deposition of collagen and the overexpression of genes involved in myofibroblast activation, was found 6 months post-irradiation. Using an in vitro co-culture system, involving directly irradiated skeletal muscle and unirradiated ventricular cardiac human cells, we propose the role of miR-1/133a as mediators of the abscopal response, suggesting that miRNA-based strategies could be relevant for limiting tissue-dependent reactions in non-directly irradiated tissues. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. p63 in corneal and epidermal differentiation.
- Author
-
Novelli, Flavia, Ganini, Carlo, Melino, Gerry, Nucci, Carlo, Han, Yuyi, Shi, Yufang, Wang, Ying, and Candi, Eleonora
- Subjects
- *
ECTODERMAL dysplasia , *DYSPLASIA , *TISSUE differentiation , *CORNEA , *STEM cells , *CELL determination - Abstract
The transcription factor p63, belonging to the p53 family, is considered the master regulator of epidermal differentiation, skin, and in general of the differentiation of ectodermal tissues. Mutations in TP63 gene cause several rare ectodermal dysplasia disorders that refers to epidermal structural abnormalities and ocular surface disease, such as Ectrodactyly Ectodermal Dysplasia Clefting (EEC) syndrome. In this review, we discuss the key roles of p63 in keratinocytes and corneal epithelial differentiation, highlighting the function of the ΔNp63α isoform in driving limbal stem cell and epithelial stem cells commitment. We have summarized the specific ocular phenotypes observed in the TP63-mutation derived EEC syndrome, discussing the current and novel therapeutic strategies for the management of the ocular manifestations in EEC syndrome. • The transcription factor p63, master regulator of epidermal differentiation, is fundamental in the development of the cornea. • TP63 mutations give rise to a few rare ectodermal dysplasia disorders, being the two major subtypes EEC and AEC. • Mutant p63 can be considered a promising target for the clinical management of ectodermal dysplasia disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. Beyond DNA repair, the immunological role of PARP-1 and its siblings
- Author
-
Rosado, Maria Manuela, Bennici, Elisabetta, Novelli, Flavia, and Pioli, Claudio
- Published
- 2013
- Full Text
- View/download PDF
14. Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women
- Author
-
Sterpone, Silvia, Mastellone, Valeria, Padua, Luca, Novelli, Flavia, Patrono, Clarice, Cornetta, Tommaso, Giammarino, Daniela, Donato, Vittorio, Testa, Antonella, and Cozzi, Renata
- Published
- 2010
- Full Text
- View/download PDF
15. Global mapping of cancers: The Cancer Genome Atlas and beyond.
- Author
-
Ganini, Carlo, Amelio, Ivano, Bertolo, Riccardo, Bove, Pierluigi, Buonomo, Oreste Claudio, Candi, Eleonora, Cipriani, Chiara, Di Daniele, Nicola, Juhl, Hartmut, Mauriello, Alessandro, Marani, Carla, Marshall, John, Melino, Sonia, Marchetti, Paolo, Montanaro, Manuela, Natale, Maria Emanuela, Novelli, Flavia, Palmieri, Giampiero, Piacentini, Mauro, and Rendina, Erino Angelo
- Abstract
Cancer genomes have been explored from the early 2000s through massive exome sequencing efforts, leading to the publication of The Cancer Genome Atlas in 2013. Sequencing techniques have been developed alongside this project and have allowed scientists to bypass the limitation of costs for whole‐genome sequencing (WGS) of single specimens by developing more accurate and extensive cancer sequencing projects, such as deep sequencing of whole genomes and transcriptomic analysis. The Pan‐Cancer Analysis of Whole Genomes recently published WGS data from more than 2600 human cancers together with almost 1200 related transcriptomes. The application of WGS on a large database allowed, for the first time in history, a global analysis of features such as molecular signatures, large structural variations and noncoding regions of the genome, as well as the evaluation of RNA alterations in the absence of underlying DNA mutations. The vast amount of data generated still needs to be thoroughly deciphered, and the advent of machine‐learning approaches will be the next step towards the generation of personalized approaches for cancer medicine. The present manuscript wants to give a broad perspective on some of the biological evidence derived from the largest sequencing attempts on human cancers so far, discussing advantages and limitations of this approach and its power in the era of machine learning. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
16. Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer
- Author
-
Terrenato Irene, Di Benedetto Anna, Siciliano Michele, Rubini Vincenza, Malfettone Andrea, Mangia Anita, Simone Giovanni, Novelli Flavia, and Mottolese Marcella
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Several studies demonstrated that epidermal growth factor receptor (EGFR) gene copy number (GCN) correlates to the response to tyrosine kinase inhibitors in non small cell lung cancer (NSCLC) and to anti-EGFR monoclonal antibodies (MoAbs) in metastatic colorectal cancer (CRC). In the presence of lung nodules, cytology is often the only possible diagnostic approach. Chromogenic in situ hybridization (CISH) is an alternative technique to fluorescence in situ hybridization (FISH), but its feasibility in detecting EGFR GCN in cell blocks from fine-needle aspiration cytology (FNAC) of lung nodules has not yet been established. Methods We evaluated the feasibility of CISH on 33 FNAC from 20 primary NSCLC (5 squamous carcinomas, 8 large cell carcinomas and 7 adenocarcinomas) and 13 lung metastases from CRC. Results Of the 33 FNAC analyzed by CISH, 27 (82%) presented a balanced increase in EGFR gene and chromosome 7 number: 10 cases (30%) showed a low polysomy, 15 (45%) a high polysomy and 2 (6%) NSCLC were amplified. No significant differences between NSCLC and CRC lung metastases were found in relation to disomic or polysomic status. In addition, no correlation between EGFR GCN and EGFR immunohistochemical overexpression was found. Furthermore, we compared CISH results with those obtained by FISH on the same samples and we found 97% overall agreement between the two assays (k = 0.78, p < 0.0001). Two cases were amplified with both assays, whereas 1 case of NSCLC was amplified by FISH only. CISH sensitivity was 67%, the specificity and positive predictive value (PPV) was 100%, and the negative predictive value (NPV) was 97%. Conclusions Our study shows that CISH is a valid method to detect EGFR GCN in cell blocks from FNAC of primary NSCLC or metastatic CRC to the lung.
- Published
- 2010
- Full Text
- View/download PDF
17. Functional expression of a single-chain antibody to ErbB-2 in plants and cell-free systems
- Author
-
Benevolo Maria, Natali Pier, Martayan Aline, Fraioli Rocco, Tornambé Andrea, Sperandei Maria, Di Donato Monica, Novelli Flavia, Pietraforte Immacolata, Lombardi Alessio, Galeffi Patrizia, Mottolese Marcella, Ylera Francisco, Cantale Cristina, and Giacomini Patrizio
- Subjects
Medicine - Abstract
Abstract Background Aberrant signaling by ErbB-2 (HER 2, Neu), a member of the human Epidermal Growth Factor (EGF) receptor family, is associated with an aggressive clinical behaviour of carcinomas, particularly breast tumors. Antibodies targeting the ErbB-2 pathway are a preferred therapeutic option for patients with advanced breast cancer, but a worldwide deficit in the manufacturing capacities of mammalian cell bioreactors is foreseen. Methods Herein, we describe a multi-platform approach for the production of recombinant Single chain Fragments of antibody variable regions (ScFvs) to ErbB-2 that involves their functional expression in (a) bacteria, (b) transient as well as stable transgenic tobacco plants, and (c) a newly developed cell-free transcription-translation system. Results An ScFv (ScFv800E6) was selected by cloning immunoglobulin sequences from murine hybridomas, and was expressed and fully functional in all the expression platforms, thereby representing the first ScFv to ErbB-2 produced in hosts other than bacteria and yeast. ScFv800E6 was optimized with respect to redox synthesis conditions. Different tags were introduced flanking the ScFv800E6 backbone, with and without spacer arms, including a novel Strep II tag that outperforms conventional streptavidin-based detection systems. ScFv800E6 was resistant to standard chemical radiolabeling procedures (i.e. Chloramine T), displayed a binding ability extremely similar to that of the parental monovalent Fab' fragment, as well as a flow cytometry performance and an equilibrium binding affinity (Ka approximately 2 × 108 M-1) only slightly lower than those of the parental bivalent antibody, suggesting that its binding site is conserved as compared to that of the parental antibody molecule. ScFv800E6 was found to be compatible with routine reagents for immunohistochemical staining. Conclusion ScFv800E6 is a useful reagent for in vitro biochemical and immunodiagnostic applications in oncology, and a candidate for future in vivo studies.
- Published
- 2006
- Full Text
- View/download PDF
18. Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy.
- Author
-
Jiaming Xue, Patergnani, Simone, Giorgi, Carlotta, Suarez, Joelle, Keisuke Goto, Bononi, Angela, Tanji, Mika, Novelli, Flavia, Pastorino, Sandra, Ronghui Xu, Caroccia, Natascia, Dogan, A. Umran, Pass, Harvey I., Tognon, Mauro, Pinton, Paolo, Gaudino, Giovanni, Tak W. Mak, Carbone, Michele, and Haining Yang
- Subjects
CELL transformation ,ASBESTOS ,CELL death ,DNA damage - Abstract
Asbestos causes malignant transformation of primary human mesothelial cells (HM), leading to mesothelioma. The mechanisms of asbestos carcinogenesis remain enigmatic, as exposure to asbestos induces HM death. However, some asbestos-exposed HM escape cell death, accumulate DNA damage, and may become transformed. We previously demonstrated that, upon asbestos exposure, HM and reactive macrophages releases the high mobility group box 1 (HMGB1) protein that becomes detectable in the tissues near asbestos deposits where HMGB1 triggers chronic inflammation. HMGB1 is also detectable in the sera of asbestos-exposed individuals and mice. Searching for additional biomarkers, we found higher levels of the autophagy marker ATG5 in sera from asbestos-exposed individuals compared to unexposed controls. As we investigated the mechanisms underlying this finding, we discovered that the release of HMGB1 upon asbestos exposure promoted autophagy, allowing a higher fraction of HM to survive asbestos exposure. HMGB1 silencing inhibited autophagy and increased asbestos-induced HM death, thereby decreasing asbestos-induced HM transformation. We demonstrate that autophagy was induced by the cytoplasmic and extracellular fractions of HMGB1 via the engagement of the RAGE receptor and Beclin 1 pathway, while nuclear HMGB1 did not participate in this process. We validated our findings in a novel unique mesothelial conditional HMGB1-knockout (HMGB1-cKO) mouse model. Compared to HMGB1 wild-type mice, mesothelial cells from HMGB1-cKO mice showed significantly reduced autophagy and increased cell death. Autophagy inhibitors chloroquine and desmethylclomipramine increased cell death and reduced asbestos-driven foci formation. In summary, HMGB1 released upon asbestos exposure induces autophagy, promoting HM survival and malignant transformation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
19. N‐glycan engineering of a plant‐produced anti‐CD20‐hIL‐2 immunocytokine significantly enhances its effector functions.
- Author
-
Marusic, Carla, Pioli, Claudio, Stelter, Szymon, Novelli, Flavia, Lonoce, Chiara, Morrocchi, Elena, Benvenuto, Eugenio, Salzano, Anna Maria, Scaloni, Andrea, and Donini, Marcello
- Abstract
Abstract: Anti‐CD20 recombinant antibodies are among the most promising therapeutics for the treatment of B‐cell malignancies such as non‐Hodgkin lymphomas. We recently demonstrated that an immunocytokine (2B8‐Fc‐hIL2), obtained by fusing an anti‐CD20 scFv‐Fc antibody derived from C2B8 mAb (rituximab) to the human interleukin 2 (hIL‐2), can be efficiently produced in
Nicotiana benthamiana plants. The purified immunocytokine (IC) bearing a typical plant protein N‐glycosylation profile showed a CD20 binding activity comparable to that of rituximab and was efficient in eliciting antibody‐dependent cell‐mediated cytotoxicity (ADCC) of human PBMC against Daudi cells, indicating its fuctional integrity. In this work, the immunocytokine devoid of the typical xylose/fucose N‐glycosylation plant signature (IC‐ΔXF) and the corresponding scFv‐Fc‐ΔXF antibody not fused to the cytokine, were obtained in a glyco‐engineered ΔXylT/FucTN. benthamiana line. Purification yields from agroinfiltrated plants amounted to 20–35 mg/kg of leaf fresh weight. When assayed for interaction with FcγRI and FcγRIIIa, IC‐ΔXF exhibited significantly enhanced binding affinities if compared to the counterpart bearing the typical plant protein N‐glycosylation profile (IC) and to rituximab. The glyco‐engineered recombinant molecules also exhibited a strongly improved ADCC and complement‐dependent cytotoxicity (CDC). Notably, our results demonstrate a reduced C1q binding of xylose/fucose carrying IC and scFv‐Fc compared to versions that lack these sugar moieties. These results demonstrate that specific N‐glycosylation alterations in recombinant products can dramatically affect the effector functions of the immunocytokine, resulting in an overall improvement of the biological functions and consequently of the therapeutic potential. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
20. Production of an active anti-CD20-hIL-2 immunocytokine in Nicotiana benthamiana.
- Author
-
Marusic, Carla, Novelli, Flavia, Salzano, Anna M., Scaloni, Andrea, Benvenuto, Eugenio, Pioli, Claudio, and Donini, Marcello
- Subjects
- *
NICOTIANA benthamiana , *CD20 antigen , *CYTOKINES , *LYMPHOMA treatment , *CANCER relapse , *LYMPHOMAS , *PATIENTS - Abstract
Anti-CD20 murine or chimeric antibodies (Abs) have been used to treat non-Hodgkin lymphomas (NHLs) and other diseases characterized by overactive or dysfunctional B cells. Anti-CD20 Abs demonstrated to be effective in inducing regression of B-cell lymphomas, although in many cases patients relapse following treatment. A promising approach to improve the outcome of mAb therapy is the use of anti-CD20 antibodies to deliver cytokines to the tumour microenvironment. In particular, IL-2-based immunocytokines have shown enhanced antitumour activity in several preclinical studies. Here, we report on the engineering of an anti-CD20-human interleukin-2 (hIL- 2) immunocytokine (2B8-Fc-hIL2) based on the C2B8 mAb (Rituximab) and the resulting ectopic expression in Nicotiana benthamiana. The scFv-Fc-engineered immunocytokine is fully assembled in plants with minor degradation products as assessed by SDS-PAGE and gel filtration. Purification yields using protein-A affinity chromatography were in the range of 15-20 mg/kg of fresh leaf weight (FW). Glycopeptide analysis confirmed the presence of a highly homogeneous plant-type glycosylation. 2B8-Fc-hIL2 and the cognate 2B8-Fc antibody, devoid of hIL-2, were assayed by flow cytometry on Daudi cells revealing a CD20 binding activity comparable to that of Rituximab and were effective in eliciting antibody-dependent cell-mediated cytotoxicity of human PBMC versus Daudi cells, demonstrating their functional integrity. In 2B8-Fc-hIL2, IL-2 accessibility and biological activity were verified by flow cytometry and cell proliferation assay. To our knowledge, this is the first example of a recombinant immunocytokine based on the therapeutic Rituximab antibody scaffold, whose expression in plants may be a valuable tool for NHLs treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
21. Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer.
- Author
-
Simone, Giovanni, Mangia, Anita, Malfettone, Andrea, Rubini, Vincenza, Siciliano, Michele, Di Benedetto, Anna, Terrenato, Irene, Novelli, Flavia, and Mottolese, Marcella
- Subjects
CHROMOGENIC bacteria ,IN situ hybridization ,LUNG cancer ,CELLS ,CANCER invasiveness ,COLON cancer ,CYTOKINES ,GROWTH factors ,METASTASIS - Abstract
Background: Several studies demonstrated that epidermal growth factor receptor (EGFR) gene copy number (GCN) correlates to the response to tyrosine kinase inhibitors in non small cell lung cancer (NSCLC) and to anti- EGFR monoclonal antibodies (MoAbs) in metastatic colorectal cancer (CRC). In the presence of lung nodules, cytology is often the only possible diagnostic approach. Chromogenic in situ hybridization (CISH) is an alternative technique to fluorescence in situ hybridization (FISH), but its feasibility in detecting EGFR GCN in cell blocks from fine-needle aspiration cytology (FNAC) of lung nodules has not yet been established. Methods: We evaluated the feasibility of CISH on 33 FNAC from 20 primary NSCLC (5 squamous carcinomas, 8 large cell carcinomas and 7 adenocarcinomas) and 13 lung metastases from CRC. Results: Of the 33 FNAC analyzed by CISH, 27 (82%) presented a balanced increase in EGFR gene and chromosome 7 number: 10 cases (30%) showed a low polysomy, 15 (45%) a high polysomy and 2 (6%) NSCLC were amplified. No significant differences between NSCLC and CRC lung metastases were found in relation to disomic or polysomic status. In addition, no correlation between EGFR GCN and EGFR immunohistochemical overexpression was found. Furthermore, we compared CISH results with those obtained by FISH on the same samples and we found 97% overall agreement between the two assays (k = 0.78, p < 0.0001). Two cases were amplified with both assays, whereas 1 case of NSCLC was amplified by FISH only. CISH sensitivity was 67%, the specificity and positive predictive value (PPV) was 100%, and the negative predictive value (NPV) was 97%. Conclusions: Our study shows that CISH is a valid method to detect EGFR GCN in cell blocks from FNAC of primary NSCLC or metastatic CRC to the lung. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
22. Chromogenic In Situ Hybridization to Detect HER-2/neu Gene Amplification in Histological and ThinPrep-Processed Breast Cancer Fine-Needle Aspirates: A Sensitive and Practical Method in the Trastuzumab Era.
- Author
-
VOCATURO, AMINA, NOVELLI, FLAVIA, BENEVOLO, MARIA, PIPERNO, GIULIA, MARANDINO, FERDINANDO, CIANCIULLI, ANNA MARIA, MEROLA, ROBERTA, DONNORSO, RAFFAELE PERRONE, SPERDUTI, ISABELLA, BUGLIONI, SIMONETTA, and MOTTOLESE, MARCELLA
- Subjects
HER2 gene ,BREAST cancer ,TRASTUZUMAB ,DRUG efficacy ,NEEDLE biopsy - Abstract
The increasing evidence of trastuzumab efficacy in breast cancer (BC) patients means that an accurate and reproducible evaluation of HER-2 status is of paramount importance in histological and in cytological samples. Currently, the two main methods used to analyze HER- 2 amplification or overexpression are fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC). Although the two methods are strongly correlated for histological tissue, the evaluation of tumor morphology through FISH may be difficult and fluorescence fades quickly. These limitations can be overcome by chromogenic in situ hybridization (CISH), which can visualize the amplification product along with morphological features. In view of this, in the present study, we analyzed the usefulness of CISH on formalin-fixed, paraffin-embedded (FFPE) BC specimens and investigated whether CISH can be a valid technique in the determination of HER-2 status for fine-needle aspirates (FNAs) processed by liquid-based cytology. The results we obtained in a retrospective series of 111 FFPE BC specimens demonstrated good concordance between CISH and IHC and between CISH and FISH. The former concordance was comparable with that observed between FISH and IHC. When CISH was applied to a prospective series of 53 FNAs, from surgically removed BC, our data showed evidence of a higher concordance of results between liquid-based cytology and the companion FFPE tissues using CISH rather than HercepTest™. Therefore, CISH analysis, which is a valuable and reproducible alternative to FISH for selecting breast cancer patients for trastuzumab therapy, can lower false-positive immunocytochemistry findings in ThinPrep®-processed FNAs. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
23. Functional expression of a single-chain antibody to ErbB-2 in plants and cell-free systems.
- Author
-
Galeffi, Patrizia, Lombardi, Alessio, Pietraforte, Immacolata, Novelli, Flavia, Di Donato, Monica, Sperandei, Maria, Tornambé, Andrea, Fraioli, Rocco, Martayan, Aline, Natali, Pier Giorgio, Benevolo, Maria, Mottolese, Marcella, Ylera, Francisco, Cantale, Cristina, and Giacomini, Patrizio
- Subjects
EPIDERMAL growth factor ,BREAST cancer ,IMMUNOGLOBULINS ,PROTEIN-tyrosine kinases ,IMMUNOHISTOCHEMISTRY ,ONCOLOGY - Abstract
Background: Aberrant signaling by ErbB-2 (HER 2, Neu), a member of the human Epidermal Growth Factor (EGF) receptor family, is associated with an aggressive clinical behaviour of carcinomas, particularly breast tumors. Antibodies targeting the ErbB-2 pathway are a preferred therapeutic option for patients with advanced breast cancer, but a worldwide deficit in the manufacturing capacities of mammalian cell bioreactors is foreseen. Methods: Herein, we describe a multi-platform approach for the production of recombinant Single chain Fragments of antibody variable regions (ScFvs) to ErbB-2 that involves their functional expression in (a) bacteria, (b) transient as well as stable transgenic tobacco plants, and (c) a newly developed cell-free transcription-translation system. Results: An ScFv (ScFv800E6) was selected by cloning immunoglobulin sequences from murine hybridomas, and was expressed and fully functional in all the expression platforms, thereby representing the first ScFv to ErbB-2 produced in hosts other than bacteria and yeast. ScFv800E6 was optimized with respect to redox synthesis conditions. Different tags were introduced flanking the ScFv800E6 backbone, with and without spacer arms, including a novel Strep II tag that outperforms conventional streptavidin-based detection systems. ScFv800E6 was resistant to standard chemical radiolabeling procedures (i.e. Chloramine T), displayed a binding ability extremely similar to that of the parental monovalent Fab' fragment, as well as a flow cytometry performance and an equilibrium binding affinity (Ka approximately 2 x 108 M-1) only slightly lower than those of the parental bivalent antibody, suggesting that its binding site is conserved as compared to that of the parental antibody molecule. ScFv800E6 was found to be compatible with routine reagents for immunohistochemical staining. Conclusion: ScFv800E6 is a useful reagent for in vitro biochemical and immunodiagnostic applications in oncology, and a candidate for future in vivo studies. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
24. Tomato Bushy Stunt Virus Nanoparticles as a Platform for Drug Delivery to Shh-Dependent Medulloblastoma.
- Author
-
Lico, Chiara, Tanno, Barbara, Marchetti, Luca, Novelli, Flavia, Giardullo, Paola, Arcangeli, Caterina, Pazzaglia, Simonetta, Podda, Maurizio S., Santi, Luca, Bernini, Roberta, Baschieri, Selene, and Mancuso, Mariateresa
- Subjects
DOXORUBICIN ,CENTRAL nervous system tumors ,MEDULLOBLASTOMA ,NEUROPEPTIDES ,MOLECULAR dynamics ,PLANT viruses ,NICOTIANA benthamiana - Abstract
Medulloblastoma (MB) is a primary central nervous system tumor affecting mainly young children. New strategies of drug delivery are urgent to treat MB and, in particular, the SHH-dependent subtype—the most common in infants—in whom radiotherapy is precluded due to the severe neurological side effects. Plant virus nanoparticles (NPs) represent an innovative solution for this challenge. Tomato bushy stunt virus (TBSV) was functionally characterized as a carrier for drug targeted delivery to a murine model of Shh-MB. The TBSV NPs surface was genetically engineered with peptides for brain cancer cell targeting, and the modified particles were produced on a large scale using Nicotiana benthamiana plants. Tests on primary cultures of Shh-MB cells allowed us to define the most efficient peptides able to induce specific uptake of TBSV. Immunofluorescence and molecular dynamics simulations supported the hypothesis that the specific targeting of the NPs was mediated by the interaction of the peptides with their natural partners and reinforced by the presentation in association with the virus. In vitro experiments demonstrated that the delivery of Doxorubicin through the chimeric TBSV allowed reducing the dose of the chemotherapeutic agent necessary to induce a significant decrease in tumor cells viability. Moreover, the systemic administration of TBSV NPs in MB symptomatic mice, independently of sex, confirmed the ability of the virus to reach the tumor in a specific manner. A significant advantage in the recognition of the target appeared when TBSV NPs were functionalized with the CooP peptide. Overall, these results open new perspectives for the use of TBSV as a vehicle for the targeted delivery of chemotherapeutics to MB in order to reduce early and late toxicity. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
25. p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer.
- Author
-
Smirnov, Artem, Anemona, Lucia, Novelli, Flavia, Piro, Cristina M., Annicchiarico-Petruzzelli, Margherita, Melino, Gerry, and Candi, Eleonora
- Subjects
SKIN cancer ,OZONE layer depletion ,EARLY detection of cancer ,P53 protein ,MERKEL cell carcinoma ,BREAST cancer prognosis - Abstract
Skin cancer is the most common type of cancer worldwide. Ozone depletion and climate changes might cause a further increase in the incidence rate in the future. Although the early detection of skin cancer enables it to be treated successfully, some tumours can evolve and become more aggressive, especially in the case of melanoma. Therefore, good diagnostic and prognostic markers are needed to ensure correct detection and treatment. Transcription factor p63, a member of the p53 family of proteins, plays an essential role in the development of stratified epithelia such as skin. In this paper, we conduct a comprehensive review of p63 expression in different types of skin cancer and discuss its possible use in the diagnosis and prognosis of cutaneous tumours. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
26. Enhancing the Secretion of a Glyco‐Engineered Anti‐CD20 scFv‐Fc Antibody in Hairy Root Cultures.
- Author
-
Lonoce, Chiara, Marusic, Carla, Morrocchi, Elena, Salzano, Anna Maria, Scaloni, Andrea, Novelli, Flavia, Pioli, Claudio, Feeney, Mistianne, Frigerio, Lorenzo, and Donini, Marcello
- Published
- 2019
- Full Text
- View/download PDF
27. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
- Author
-
Bria, Emilio, Visca, Paolo, Novelli, Flavia, Antoniani, Barbara, Perrone-Donnorso, Raffaele, Sperduti, Isabella, Facciolo, Francesco, Milella, Michele, Cognetti, Francesco, and Mottolese, Marcella
- Published
- 2007
- Full Text
- View/download PDF
28. Amino-terminal residues of ΔNp63, mutated in ectodermal dysplasia, are required for its transcriptional activity.
- Author
-
Lena, Anna Maria, Duca, Sara, Novelli, Flavia, Melino, Sonia, Annicchiarico-Petruzzelli, Margherita, Melino, Gerry, and Candi, Eleonora
- Subjects
- *
N-terminal residues , *GENETIC mutation , *ECTODERMAL dysplasia , *TRANSCRIPTION factors , *CHROMATIN , *DNA-binding proteins - Abstract
p63, a member of the p53 family, is a crucial transcription factor for epithelial development and skin homeostasis. Heterozygous mutations in TP63 gene have been associated with human ectodermal dysplasia disorders. Most of these TP63 mutations are missense mutations causing amino acidic substitutions at p63 DNA binding or SAM domains that reduce or abolish the transcriptional activity of mutants p63. A significant number of mutants, however, resides in part of the p63 protein that apparently do not affect DNA binding and/or transcriptional activity, such as the N-terminal domain. Here, we characterize five p63 mutations at the 5′ end of TP63 gene aiming to understand the pathogenesis of the diseases and to uncover the role of ΔNp63α N-terminus residues in determining its transactivation potential. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
29. Metabolic pathways regulated by p63.
- Author
-
Candi, Eleonora, Smirnov, Artem, Panatta, Emanuele, Lena, Anna Maria, Novelli, Flavia, Mancini, Mara, Viticchiè, Giuditta, Piro, Maria Cristina, Di Daniele, Nicola, Annicchiarico-Petruzzelli, Margherita, and Melino, Gerry
- Subjects
- *
P53 antioncogene , *CELL metabolism , *TRANSCRIPTION factors , *EPITHELIAL cells , *CANCER cell proliferation , *GENE targeting - Abstract
The transcription factor p63 belongs to the p53-family and is a master regulator of proliferative potential, lineage specification, and differentiation in epithelia during development and tissue homeostasis. In cancer, p63 contribution is isoform-specific, with both oncogenic and tumour suppressive roles attributed, for ΔNp63 and TAp63, respectively. Recently, p53 and TAp73, in line with other tumour suppressor genes, have emerged as important regulators of energy metabolism and metabolic reprogramming in cancer. To date, p63 contributions in controlling energy metabolism have been partially investigated; given the extensive interaction of the p53 family members, these studies have potential implications in tumour cells for metabolic reprogramming. Here, we review the role of p63 isoforms, TAp63 and ΔNp63, in controlling cell metabolism, focusing on their specific metabolic target genes and their physiological/functional context of action. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.